Source https://www.fightaging.org/archives/2024/06/sglt2-inhibition-is-senolytic-in-overweight-mice/
SGLT2 inhibitors are a class of diabetes medication that falls within the broad present enthusiasm for pharmacological treatments that can reduce weight in obese individuals. In today’s open access paper, researchers demonstrate that the SGLT2 inhibitor canagliflozin reduces the burden of senescent cells in obese mice fed a high fat diet. The researchers identify the mechanism as an increase in the efficiency with which immune cells clear senescent cells from tissues.
It is known that being overweight, sp…
Source https://www.fightaging.org/archives/2024/06/sglt2-inhibition-is-senolytic-in-overweight-mice/
SGLT2 inhibitors are a class of diabetes medication that falls within the broad present enthusiasm for pharmacological treatments that can reduce weight in obese individuals. In today’s open access paper, researchers demonstrate that the SGLT2 inhibitor canagliflozin reduces the burden of senescent cells in obese mice fed a high fat diet. The researchers identify the mechanism as an increase in the efficiency with which immune cells clear senescent cells from tissues.
It is known that being overweight, sp…
What Do You Think?
comments